Imported-post
-
Phase 3 CELLEBRATE Trial testing regenerative stem cell-based therapy to improve urinary control for women
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. Read MoreMar 11, 2024
-
Blood mutations increase risk for acute kidney injury: study
A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide. Read MoreMar 7, 2024
-
Center for Democracy and Technology names Wisniewski, Davis to 2024-2026 fellows program
Pamela Wisniewski, associate professor in human-computer interaction and Flowers Faculty Fellow in the School of Engineering, has been named to the 2024–26 class of nonresident fellows at the Center for Democracy and Technology, a leading nonpartisan nonprofit in Washington, D.C., working to advance civil rights and civil liberties in the digital age. Jenny Davis, professor of […] Read MoreMar 4, 2024
-
Lippmann wins prestigious Chan Zuckerberg Initiative award to back research in the fight against Alzheimer’s
Ethan Lippmann, associate professor of chemical and biomolecular engineering and biomedical engineering, has won a Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative (CZI) to create a more effective way for the immune system to fight against neurodegenerative diseases like Alzheimer’s. The pilot project seeks to generate an immune response – or defense […] Read MoreFeb 27, 2024
-
Vanderbilt biochemists discover breakthrough anti-evolution compound to combat antibiotic resistance
The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read MoreFeb 26, 2024
-
Exploring the basics of neurological disorders: Calcium transport in receptors
Led by Terunaga Nakagawa, an international collaboration describes for the first time the fundamental mechanism underpinning cellular processes that lead to learning and memory. Read MoreFeb 26, 2024
-
Researchers develop new nanoparticle to boost immune system
Vanderbilt researchers have developed a new nanoparticle that can more effectively get drugs inside of cells to boost the immune system and fight diseases like cancer. The research is led by John Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, as well as a corresponding author on the paper about the research […] Read MoreFeb 23, 2024
-
Waddell Walker Hancock Cancer Discovery Fund names Wilson and Rathmell as first scholars
A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund. The project to create an immunotherapy that will benefit more patients is led by John Tanner Wilson, left, and Jeffrey Rathmell. (photo by Donn Jones) […] Read MoreFeb 22, 2024
-
Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes
An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally. Read MoreFeb 21, 2024
-
VUMC part of major step to achieving precision medicine
An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences. Read MoreFeb 19, 2024
-
Vanderbilt nanodrug may be a paradigm shift for cancer
A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic “microenvironment” without harming normal tissue. Read MoreFeb 7, 2024
-
VUMC study finds molecular switch key to repair of kidney damage
Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair. Read MoreFeb 7, 2024
-
Weimer receives NSF CAREER Award to improve safety and efficacy of machine learning, AI systems
James Weimer, assistant professor of computer science and noted medical-device entrepreneur, has received a National Science Foundation CAREER Award to improve the safety and efficacy of systems that use advanced machine learning and artificial intelligence techniques. Learning-enabled medical cyber-physical systems (LE-MCPS) are smart medical systems that provide actionable feedback to caregivers. They use machine learning... Read MoreFeb 1, 2024
-
Fatty acids rewire energy supply chain in stomach cancer development
A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer. Read MoreJan 31, 2024
-
3D brain mapping opens a window to the aging brain
By mapping brain activity in three dimensions, researchers at Vanderbilt University Medical Center have achieved a more detailed picture of how the brain changes with age. Read MoreJan 30, 2024
-
Vanderbilt achieves NSA designation as a Center of Academic Excellence in Cyber Research
The U.S. National Security Agency (NSA) has designated Vanderbilt University as a Center of Academic Excellence in Cyber Research, positioning the university as a premier institution for cyber-related education and innovation. Each year, cybercrime grows as a threat to national security and vital U.S. interests around the world. In addition to the rise of increasingly... Read MoreJan 23, 2024
-
The big picture: Archaeology of the Andes revealed on a scale not previously seen
Steven Wernke, associate professor and chair of anthropology, has developed GeoPACHA (Geospatial Platform for Andean Culture, History and Archaeology), a web application that allows researchers to map archaeological sites in the Andes at a greater scale than ever before. Read MoreJan 19, 2024
-
New NIH grant funds novel brain network approach to improve epilepsy surgery
A multidisciplinary group of investigators from Vanderbilt University Medical Center, Vanderbilt University, and the University of Pennsylvania received a $3.2 million grant to develop novel brain network-based measures to guide surgical decisions and improve outcomes in the field of epilepsy surgery. Epilepsy is a debilitating neurological disorder where seizures are often resistant to medications, but... Read MoreJan 18, 2024
-
Hartmann named director of UK Center for Clinical and Translational Science
Katherine Hartmann, MD, PhD, Vice President for Research Integration for Vanderbilt University Medical Center, has been named director of the University of Kentucky (UK) Center for Clinical and Translational Science. Read MoreJan 17, 2024
-
‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art
The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology, and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool. Read MoreJan 16, 2024